detect
plasmodium
parasit
peripher
blood
febril
patient
asymptomat
carrier
essenti
malaria
control
programm
aim
decreas
local
transmiss
achiev
preelimin
recent
launch
global
initi
known
test
treat
track
aim
support
malariaendem
countri
effort
achiev
univers
coverag
diagnost
test
antimalari
treatment
though
malaria
elimin
europ
north
america
diagnost
tool
seem
difficult
tropic
countri
includ
subsaharan
africa
substanti
number
individu
harbour
malaria
infect
extrem
low
densiti
undetect
current
avail
tool
diagnos
malaria
includ
microscopi
parasit
antigenenzym
detect
kit
commonli
refer
rapid
diagnost
test
rdt
molecular
tool
discuss
cordray
specif
advantag
limit
potenti
deploy
differ
level
health
system
microscopi
rdt
peripher
molecular
tool
inde
microscopi
rdt
remain
feasibl
option
health
facil
lower
level
eg
commun
case
manag
two
diagnost
tool
limit
exampl
absenc
gene
encod
protein
antigen
detect
test
direct
plasmodium
falciparum
popul
endem
area
result
substanti
proport
fals
moreov
microscopi
rdt
detect
parasit
densiti
particularli
field
condit
asymptomat
carrier
much
lower
parasit
latter
identifi
nucleic
acid
amplif
test
naat
often
pcr
one
wide
use
molecular
method
detect
identif
infecti
diseas
detect
limit
pcr
depend
assay
lower
either
rdt
microscopi
pcr
therefor
abl
detect
asymptomat
malaria
carrier
may
target
set
asymptomat
sexual
asexu
stage
p
falciparum
infect
may
persist
sustain
transmiss
low
parasit
densiti
threshold
detect
microscopi
rdt
reach
molecular
method
howev
pcrbase
assay
least
feasibl
perform
field
set
prone
contamin
heavili
influenc
puriti
sampl
nucleic
acid
content
thu
reli
purifi
extract
requir
cold
storag
facil
therefor
recent
molecular
diagnost
method
requir
special
equip
personnel
could
carri
outsid
refer
facil
possibl
amplifi
dna
isotherm
temperatur
without
need
thermocycl
apparatu
creat
opportun
perform
molecular
diagnost
test
peripher
thu
improv
manag
infecti
diseas
especi
resourcelimit
recent
guidelin
publish
recommend
diagnost
devic
resourcelimit
set
assur
afford
sensit
specif
userfriendli
rapid
robust
equipmentfre
deliver
end
paper
review
molecular
isotherm
amplif
techniqu
assur
criteria
mind
aim
determin
possibl
deploy
highthroughput
detect
asymptomat
p
falciparum
carrier
field
eg
mass
screen
treatment
campaign
prepar
sampl
molecular
assay
bottleneck
naat
involv
lengthi
process
often
perform
dna
extract
molecular
assay
critic
step
differ
method
result
differ
yield
qualiti
nucleic
one
major
problem
particularli
process
larg
quantiti
sampl
inhibit
pcr
haem
red
blood
cell
obtain
crude
dna
ideal
dna
extract
method
follow
characterist
rapid
prepar
high
throughput
high
reliabl
product
goodqual
dna
longterm
storag
avoid
crosscontamin
reason
sever
isotherm
technolog
may
fulfil
requir
appear
less
affect
inhibitori
effect
blood
product
similar
sensit
specif
standard
pcr
dna
extract
use
crude
method
heat
new
approach
simplifi
pcr
field
set
includ
assay
less
prone
inhibit
palmheld
pcr
devic
ahram
featur
three
stage
special
structur
heat
block
maintain
temperatur
suitabl
three
pcr
step
sampl
circul
across
high
lowtemperatur
zone
insid
sampl
tube
field
pcr
unit
portabl
realtim
pcr
system
freezedri
reagent
develop
biofir
diagnost
mobil
analyt
laboratori
field
hospit
pathogen
labonchip
pointofcar
diagnost
assay
also
design
diagnosi
diseas
howev
assay
still
rel
expens
resourcelimit
set
entir
infrastructurefre
postamplif
detect
also
simplifi
develop
acid
lateralflow
immun
base
new
find
dnarna
synthesi
nonpcrbas
method
nucleic
acid
amplif
involv
use
accessori
protein
mimick
vitro
nucleic
acid
amplif
isotherm
approach
facilit
rapid
target
amplif
singletemperatur
incub
reduc
system
complex
compar
pcrbase
method
establish
isotherm
amplif
method
differ
degre
complex
multipl
enzym
primer
also
vari
sensit
major
advantag
isotherm
amplif
method
simplic
endpoint
determin
often
visual
observ
allow
assay
run
close
system
thu
reduc
risk
postamplif
choic
reaction
use
primarili
driven
target
interest
amplifi
amplif
time
reaction
temperatur
toler
substanc
biolog
sampl
length
target
initi
heat
denatur
complex
ie
number
enzym
primer
requir
factor
consid
choos
appropri
past
two
decad
sever
isotherm
amplif
method
detect
pathogen
includ
malaria
parasit
use
tabl
lamp
first
describ
perform
simplifi
inexpens
specimen
process
isotherm
condit
simpl
heat
block
water
bath
furthermor
format
visual
detect
without
need
instrument
major
advantag
field
lamp
onestep
amplif
reaction
employ
selfrecur
stranddisplac
synthesi
prime
special
design
set
primer
identifi
six
distinct
sequenc
target
detail
review
principl
primer
setup
design
avail
cost
rang
usd
use
readymad
reaction
mixtur
prepar
individu
reagent
usd
use
commerci
avail
reaction
mixtur
lamp
assay
proffer
cheaper
pcr
assay
howev
one
major
shortfal
lamp
assay
complex
primer
assay
design
optim
tabl
use
lamp
diagnosi
variou
diseas
includ
human
malaria
investig
lower
limit
detect
rang
sensit
specif
compar
rrna
gene
pcr
assay
use
crude
dna
extract
respect
tabl
howev
subsequ
studi
use
pcr
lamp
protocol
report
much
lower
estim
sensit
specif
ie
take
microscopi
gold
standard
differ
primer
set
target
gene
sensit
specif
field
sampl
collect
thailand
use
composit
refer
diagnosi
sampl
ie
two
three
test
microscopi
nest
pcr
npcr
lamp
give
result
lamp
sensit
specif
p
falciparum
primer
target
mitochondri
genom
npcr
assay
refer
test
sensit
specif
recent
studi
uganda
sensit
specif
lamp
p
falciparum
primer
respect
genu
recent
comparison
optim
lamp
protocol
highli
sensit
threewel
npcr
refer
assay
amplif
well
three
replic
per
sampl
count
posit
lamp
show
sensit
compar
lamp
also
report
detect
plasmodium
speci
includ
plasmodium
malaria
plasmodium
human
plasmodium
knowlesi
gametocyt
revers
transcript
show
eas
adapt
method
nasba
first
describ
kievit
et
homogen
isotherm
nucleic
acid
amplif
method
particularli
suit
rna
target
doublestrand
dna
background
cocktail
three
enzym
revers
transcriptas
rna
polymeras
rnase
h
act
concert
allow
rapid
amplif
target
sequenc
without
use
expens
thermalcycl
equip
end
product
singlestrand
rna
antisens
origin
rna
sinc
dna
denatur
step
nasba
contamin
genom
provir
dna
precursor
latent
form
viru
integr
genet
materi
host
cell
amplifi
howev
extent
reaction
control
adjust
number
cycl
likelihood
nonspecif
interact
increas
amplif
temperatur
exceed
without
risk
enzymat
reliabl
nasba
process
test
sequenc
rna
product
directli
nasba
reaction
sequenc
readabl
excel
result
consid
rich
p
falciparum
detect
semiquantif
malaria
parasit
speci
identif
nasba
compar
microscopi
sensit
specif
anoth
studi
detect
product
nasba
amplif
electrochemiluminesc
report
sensit
specif
schneider
et
report
signific
correl
parasit
quantif
result
realtim
quantit
nasba
qtnasba
realtim
quantit
pcr
qtpcr
qtnasba
also
use
determin
gametocyt
carriag
preval
densiti
abil
detect
gametocyt
densiti
low
cost
nasba
assay
determin
howev
consid
nasba
requir
similar
consum
infrastructur
pcr
expect
assay
cost
would
similar
tabl
system
first
describ
strand
duplex
dna
separ
dna
helicas
coat
singlestrand
dnabind
protein
ssb
sequencespecif
primer
hybrid
border
target
dna
dna
polymeras
extend
primer
anneal
templat
produc
doublestrand
dna
figur
two
newli
synthes
doublestrand
dna
product
subsequ
use
substrat
dna
helicas
enter
next
round
reaction
thu
simultan
chain
reaction
proce
result
exponenti
amplif
select
target
thda
amplifi
nucleic
acid
target
effici
requir
fewer
protein
compon
mesophil
hda
platform
perform
howev
method
isotherm
requir
thermocycl
present
rel
cheaper
platform
pcr
thda
platform
success
use
detect
sever
compar
cultur
method
detect
helicobact
pylori
thdaelisa
sensit
specif
respect
higher
sensit
specif
compar
howev
use
colorimetr
detect
gold
nanoparticl
probe
sensit
higher
compar
cultur
method
histolog
specif
similar
higher
compar
cultur
method
histolog
detect
sensit
specif
detect
differ
pathogen
higher
amplifi
dna
appli
onto
verticalflow
strip
embed
dispos
cassett
tabl
recent
clinic
analyt
perform
thda
plasmodium
detect
specieslevel
identif
blood
sampl
report
overal
sensit
ci
specif
ci
adapt
thda
microarray
platform
carri
directli
surfac
glass
slide
immobil
one
primer
glass
substrat
leav
correspond
primer
solut
helicas
unwind
dna
templat
result
dna
singl
strand
abl
anneal
immobil
primer
subsequ
elong
dna
polymeras
label
correspond
primer
report
allow
success
detect
amplifi
target
microarray
platform
laser
scan
total
intern
reflect
fluoresc
rpa
isotherm
amplif
specif
dna
fragment
achiev
bind
oppos
oligonucleotid
primer
templat
dna
extens
dna
polymeras
global
melt
templat
requir
primer
direct
complementari
target
sequenc
instead
rpa
employ
complex
scan
doublestrand
dna
facilit
strand
exchang
cognat
result
structur
stabil
ssb
interact
displac
templat
strand
thu
prevent
eject
primer
branch
migrat
figur
recombinas
disassembl
leav
oligonucleotid
access
stranddisplac
dna
polymeras
case
larg
fragment
bacillu
subtili
poli
bsu
primer
extens
ensu
exponenti
amplif
accomplish
cyclic
repetit
process
key
rpa
establish
dynam
reaction
environ
balanc
format
disassembl
reaction
system
provid
stabil
dri
format
may
permit
transport
limit
storag
without
refriger
even
though
longterm
storag
refriger
still
rpa
also
recent
report
slipchip
microfluid
platform
enabl
multistep
manipul
parallel
larg
number
small
volum
consist
two
plate
contain
well
duct
brought
contact
move
rel
one
anoth
manipul
fluid
creat
break
fluidic
recent
highli
sensit
isotherm
rpa
assay
detect
rift
valley
fever
viru
rvfv
rna
mobil
devic
publish
though
assay
yet
valid
clinic
sda
base
abil
restrict
enzym
nick
cut
unmodifi
strand
hemiphosphorothio
form
recognit
site
well
abil
dna
polymeras
initi
replic
cut
site
displac
downstream
nontempl
strand
primer
contain
recognit
site
nick
restrict
enzym
bind
opposit
strand
target
dna
posit
flank
sequenc
amplifi
target
fragment
exponenti
amplifi
coupl
sens
antisens
reaction
strand
displac
sens
reaction
serv
target
antisens
reaction
vice
method
consist
two
part
figur
target
gener
process
make
copi
target
sequenc
flank
enzym
restrict
site
ii
exponenti
amplif
modifi
target
sequenc
repeat
nick
strand
displac
prime
displac
despit
seemingli
complic
sequenc
event
sda
oper
simpl
protocol
target
dna
heat
denatur
presenc
reagent
except
restrict
enzym
polymeras
amplif
proce
cool
addit
amplifi
product
may
detect
varieti
origin
sda
process
effici
improv
incorpor
thermost
polymeras
differ
exonucleas
increas
yield
rate
amplif
new
condit
allow
amplif
target
min
sda
also
use
detect
rna
incorpor
revers
transcript
vari
sensit
specif
report
diagnosi
mycobacterium
tuberculosi
neisseria
gonorrhoea
chlamydia
trachomati
enterohaemorrhag
escherichia
coli
tabl
isotherm
amplif
techniqu
potenti
field
diagnosi
malaria
infect
elimin
need
costli
powerintens
thermocycl
produc
result
short
time
min
h
use
process
larg
number
sampl
requir
activ
surveil
capabl
detect
infect
blood
sexual
asexu
sensit
specif
techniqu
compar
pcrbase
howev
note
isotherm
amplif
techniqu
though
rel
cheaper
pcr
total
equip
infrastructurefre
rather
better
potenti
field
deploy
due
simplifi
amplif
condit
thu
altern
heat
sourc
one
major
limit
field
deploy
isotherm
amplif
assay
endpoint
detect
amplifi
product
realtim
fluoresc
turbid
measur
reliabl
method
postamplif
lamp
assay
posit
sampl
visual
identifi
nake
eye
result
white
precipit
magnesium
pyrophosph
form
adapt
verticalflow
strip
embed
dispos
cassett
labonchip
portabl
devic
endpoint
detect
amplifi
product
isotherm
amplif
assay
would
userfriendli
field
foundat
innov
new
diagnost
work
hospit
tropic
diseas
london
eiken
chemic
compani
japan
develop
simplifi
lamp
assay
diagnosi
malaria
prototyp
test
compar
pcr
use
sampl
febril
patient
two
clinic
trial
one
london
travel
endem
set
place
lamp
forefront
isotherm
amplif
assay
potenti
replac
pcr
nearest
futur
commerci
lamp
reaction
kit
also
develop
recent
numer
viral
bacteri
protozoan
combin
lamp
lab
chip
diagnosi
perform
singleus
devic
would
offer
sensit
altern
microscopi
global
malaria
map
continu
shrink
elimin
serious
consid
certain
territori
activ
detect
asymptomat
carrier
may
scale
region
therefor
robust
fielddeploy
molecularbas
assay
abl
give
result
compar
laboratorybas
assay
use
crude
sampl
sourc
simpl
end
product
detect
would
best
approach
handl
larg
number
sampl
would
gener
develop
isotherm
amplif
techniqu
pave
way
none
declar
